What Is RAG in Healthcare?   Retrieval-augmented generation, or RAG in healthcare, is an approach that allows a generative AI system to find relevant information from trusted healthcare sources before creating a response.

Software architecture for AI systems defines how models, data, applications, APIs, business tools, security controls, monitoring, and infrastructure work together as one system.

A product team can spend weeks building an AI feature that works perfectly during testing. The demo looks good, the team is happy with the results and the feature is ready for real users. The problem often appears later, when thousands of people start using it and the AI bill begins to grow much faster than expected. 

  AI for UI design automation is reshaping how product teams design, validate, and ship interfaces, compressing timelines, reducing rework, and accelerating time-to-market at scale. Read more to understand how AI-driven UI design automation can help your teams ship faster.

This blog is about how vibe coding alone falls short in production systems, and why context-aware AI, with strong governance and architectural discipline, is key to reliable, scalable software.

This guide is for decision-makers, strategists, tech leaders, and forward-thinking organizations preparing for the Gen AI shift. If you are exploring which Gen AI trends will rule 2026, this blog will help you anticipate what’s coming and decide your course of action.

Accounting has always been about precision and timeliness. But for decades, these goals have conflicted with each other. You could have accuracy if you invested enough time, or you could have speed if you accepted a margin of error. Today, AI in accounting software is changing that equation entirely.

AI is no longer an abstract concept in healthcare, from accelerating diagnostics and optimizing treatment plans to enhancing operational workflows and patient engagement. Yet, not every AI innovation delivers equal value. According to a report by Gitnux, the global AI‑in‑healthcare market is projected to grow from $45.2 billion in 2026 to $188 billion by 2030. While some technologies are already reshaping clinical practices, others remain in experimental stages or are overhyped with minimal real-world impact.